The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Registration now open for the webinar 𝘿𝙚𝙨𝙚𝙣𝙨𝙞𝙩𝙞𝙨𝙖𝙩𝙞𝙤𝙣 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙚𝙨 on 𝗧𝘂𝗲𝘀𝗱𝗮𝘆, 𝟭 𝗠𝗮𝗿𝗰𝗵 𝗮𝘁 𝟭𝟴:𝟬𝟬 𝗖𝗘𝗧!
With Prof. Nizam Mamode & Prof. Christophe Legendre
This activity is sponsored by Hansa Biopharma
Register now!
Following the TLJ 2.0 event last November, two important papers have been published in Transplant International focusing on the meeting’s Workstream 4: Normothermic regional perfusion (NRP) in donation after circulatory death (DCD). One paper concerns a systematic review and meta-analyses of NRP in DCD donation, with the other focuses on a consensus statement on the
A double appointment this week with the #ESOTchat on twitter at 21:00 CEST (for 30 minutes): Monday is #ESOTTLJ WS06 on recommendations concerning the management of the patient with HLA antibodies Wednesday is #ESOTcongress on people with transplants at the centre See you on Twitter!
Recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies We are pleased to present the recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies. Over recent months, our group
As part of the TLJ 2.0, Workstream 6 has been considering the management of patients with HLA antibodies, with the aim of publishing a clinical guideline. On 28 August a meeting will take place in Milan with experts in the field and the wider clinical community to discuss the latest draft, after which the guideline
An assessment of the impact of COVID-19 on transplantation practice, one year from the start of the pandemic.
A working group of European experts has summarised the current technique and logistical aspects as they are implemented in their countries and / or centres. From these discussions, and supported by literature, the TJL2.0 Work Stream has created a list of recommendations and minimal requirements any NRP programme should follow. We ask your help to
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
This pre-print from TLJ 2.0 WS03 on ‘Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancer’ is now open for comments on Transplant Live. Led by Umberto Maggiore, this paper will be submitted to Transplant International once feedback from our community has been collated. Login & provide your input today
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the World’s leading transplant experts. Read the TLJ20Report for the
